Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

GRITSTONE BIO, INC.

(GRTS)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur GRITSTONE BIO, INC.
25/01Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/01Gritstone Starts Enrollment in Phase 2/3 Trial of Colorectal Cancer Vaccine
13/01Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
13/01Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
10/01GRITSTONE BIO, INC. : Results of Operations and Financial Condition (form 8-K)
06/01UNIVERSITY OF MANCHESTER : Early data for multivariant COVID-19 vaccine booster shows prom..
05/01GRITSTONE BIO : Announces Positive Clinical Results from First Cohort of a Phase 1 Study (..
04/01GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
04/01Gritstone Reports Positive Data From Study of Second-Generation COVID-19 Vaccine; Share..
04/01Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (COR..
04/01Gritstone Bio, Inc. Announces Positive Clinical Results from First Cohort of A Phase 1 ..
2021Gritstone Announces Presentations during Three Upcoming Investor Conferences
2021GRITSTONE BIO, INC.(NASDAQGS : GRTS) added to NASDAQ Biotechnology Index
2021GRITSTONE BIO, INC.(NASDAQGS : GRTS) added to S&P Biotechnology Select Industry Index
2021GRITSTONE BIO : Announces Changes to Its Board of Directors - Form 8-K
2021GRITSTONE BIO, INC. : Change in Directors or Principal Officers, Financial Statements and ..
2021Gritstone Announces Changes to Its Board of Directors
2021Gritstone bio, Inc. Announces Executive Changes
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Gritstone Bio to Be Added to Nasdaq Biotechnology Index on Dec. 20
2021Gritstone bio Added to the Nasdaq Biotechnology Index
2021Omicron is a wake-up call for COVID-19 vaccine developers
2021Gritstone Oncology Expands Vaccine Agreement With Coalition for Epidemic Preparedness I..
2021Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant
2021Gritstone Expects 'Minimal Impact' From Omicron Variant on T Cell Epitope Constructs in..
2021The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets) C..
2021Gritstone bio, Inc Announces Omicron Variant of SARS-CoV-2 has Minimal Impact on the T ..
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Gritstone Bio Says Experimental COVID-19 Vaccine Produced Immune Response in Monkeys, M..
2021Gritstone Announces Positive Preclinical Data in Non-Human Primate Challenge Study with..
2021Gritstone bio, Inc. Announces Positive Preclinical Data in Non-Human Primate Challenge ..
2021Earnings Flash (GRTS) GRITSTONE BIO Posts Q3 Revenue $2.6M
2021Earnings Flash (GRTS) GRITSTONE BIO Posts Q3 Loss $-0.36
2021GRITSTONE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
2021Gritstone bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ende..
2021Gritstone Reports Third Quarter 2021 Financial Results and Business Update
2021GRITSTONE BIO : Announces Presentations during Five Upcoming Investor Conferences and Even..
2021GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
2021Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021ASTRAZENECA : invests in Imperial's self-amplifying RNA technology with eye on future drug..
2021GRITSTONE BIO : Oncology Doses First Volunteer in Phase 1 Trial of COVID-19 Vaccine Booste..
2021GRITSTONE BIO : Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mR..
2021Gritstone Announces Dosing of First Volunteer in Trial Evaluating Self-Amplifying mRNA ..
2021GRITSTONE BIO, INC.(NASDAQGS : GRTS) added to S&P Global BMI Index
2021GRITSTONE BIO : SECURITIES PURCHASE AGREEMENT (Form 8-K)
2021GRITSTONE BIO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equ..
2021AFTER HOURS WATCH LIST SCORECARD : Abcl, fang, grts
2021GRITSTONE BIO : Doses First Solid Tumor Patient With Optimized Drug Candidate in Phase 2 C..
2021GRITSTONE BIO : Announces Dosing of First Solid Tumor Patient with Optimized SLATE “..
2021Gritstone Announces Positive Clinical Data with GRANITE (Individualized Neoantigen Immu..
2021Gritstone Bio, Inc. Announces Dosing of First Solid Tumor Patient with Optimized SLATE ..
2021Gritstone Bio, Inc. Announces Update Results from the Phase 1/2 Study Evaluating the Sa..
2021MT NEWSWIRES AFTER HOURS WATCH LIST : Abcl, fang, grts
2021GRITSTONE BIO : Oncology Places 5 Million Shares for $55 Million -- Stock Down 5% After-Ho..
2021GRITSTONE BIO : Announces Private Placement Financing of $55.0 Million
2021Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Soli..
2021Gritstone to Host Data Update on Neoantigen Oncology Programs for the Treatment of Soli..
2021GRITSTONE BIO : Announces Presentations at Two Investor Conferences in September
2021GRITSTONE BIO : Secures Funding to Develop COVID-19 Vaccine Program
2021GRITSTONE BIO : secures funding for COVID-19 vaccine against variants
2021GRITSTONE BIO : in funding deal with CEPI for COVID-19 vaccine against variants
2021GRITSTONE BIO : and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine ..
2021GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021GRITSTONE BIO : and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine ..
2021Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Pro..
2021GRITSTONE BIO : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021Gritstone to Host Key Opinion Leader Webinar on its Neoantigen Oncology Programs
2021GRITSTONE BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
2021Gritstone Bio, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021GRITSTONE BIO : Reports Second Quarter 2021 Financial Results and Business Update
2021GRITSTONE BIO : Earnings Flash (GRTS) GRITSTONE BIO Reports Q2 Loss $-0.33
2021GRITSTONE BIO : Earnings Flash (GRTS) GRITSTONE BIO Posts Q2 Revenue $2.8M
2021GRITSTONE BIO : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell Small Cap Comp Growth Index
2021GRITSTONE BIO, INC.(NASDAQGS : GRTS) dropped from Russell 2000 Growth Index
1  2  3  4Suiv.
Prochain événement sur GRITSTONE BIO, INC.